about
Redox Signaling in Diabetic Nephropathy: Hypertrophy versus Death Choices in Mesangial Cells and PodocytesThe balance of powers: Redox regulation of fibrogenic pathways in kidney injuryReactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical IndicationsRAGE and CYBA polymorphisms are associated with microalbuminuria and end-stage renal disease onset in a cohort of type 1 diabetes mellitus patients over a 20-year follow-upMini-review: emerging roles of microRNAs in the pathophysiology of renal diseasesBrd4 inhibition attenuates unilateral ureteral obstruction-induced fibrosis by blocking TGF-β-mediated Nox4 expressionCRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa CellsPlumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling.Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.Decoding NADPH oxidase 4 expression in human tumors.5-Lypoxygenase products are involved in renal tubulointerstitial injury induced by albumin overload in proximal tubules in mice.Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy.Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.PhenoMiner: a quantitative phenotype database for the laboratory rat, Rattus norvegicus. Application in hypertension and renal disease.Reactive oxygen species as important determinants of medullary flow, sodium excretion, and hypertensionp47(phox) contributes to albuminuria and kidney fibrosis in mice.Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: LINKING CYTOSKELETAL ORGANIZATION TO REDOX STATE.Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy.MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.NADPH oxidase 4 regulates homocysteine metabolism and protects against acetaminophen-induced liver damage in miceMetabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney DiseaseMatrix metalloproteinase 12 modulates high-fat-diet induced glomerular fibrogenesis and inflammation in a mouse model of obesityThe NADPH oxidase Nox4 has anti-atherosclerotic functions.The Endoplasmic Reticulum Chaperone Calnexin Is a NADPH Oxidase NOX4 Interacting Protein.Role of Nox2 in diabetic kidney disease.Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).MicroRNAs: potential mediators and biomarkers of diabetic complications.Redox signaling is an early event in the pathogenesis of renovascular hypertension.Diabetes and Kidney Disease: Role of Oxidative Stress.NADPH oxidase 4 deficiency increases tubular cell death during acute ischemic reperfusion injury.NADPH oxidase 4 deficiency reduces aquaporin-2 mRNA expression in cultured renal collecting duct principal cells via increased PDE3 and PDE4 activity.Calcineurin Aβ regulates NADPH oxidase (Nox) expression and activity via nuclear factor of activated T cells (NFAT) in response to high glucose.Activation of NADPH oxidase 4 in the endoplasmic reticulum promotes cardiomyocyte autophagy and survival during energy stress through the protein kinase RNA-activated-like endoplasmic reticulum kinase/eukaryotic initiation factor 2α/activating transNephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.From form to function: the role of Nox4 in the cardiovascular system.Nox4 and diabetic nephropathy: with a friend like this, who needs enemies?The signaling pathway of NADPH oxidase and its role in glomerular diseases.Novel targets of antifibrotic and anti-inflammatory treatment in CKD.The pathobiology of diabetic vascular complications--cardiovascular and kidney disease.
P2860
Q26778527-25FE2299-A60A-4F08-83EC-BD67C3608BB5Q26786137-3D5417F2-AF50-4E58-87F2-CFFDD549BC26Q27024762-34A3583E-D1B1-4311-AFDF-03AE01DD5526Q28270272-BABB6474-E544-4E4E-80AA-FD040143A9E5Q28354033-722DC0A6-3542-4996-8C1C-BB8797EA56B9Q28817822-2E1E645F-8C88-4048-9787-61ECB7F30F8AQ29248696-F3576435-4FD4-46FE-AD9E-85CA2E16604DQ31133726-C5771010-F9C4-4FC6-8A5C-86B52EEC3BB6Q33660629-B95B5B0C-6F64-499E-9F5B-BB972906DB82Q33761274-9D4EBC9E-2ED7-4837-9DB7-B22BA8137BA6Q34323094-3E56EF15-4AB2-400F-A8D8-A0DA69548F3CQ34631886-DB42BB09-D015-42EF-A6FE-B3BC032FDDBBQ34978108-C3E29A1B-FBA9-4F6F-BFE9-66B99C255CD1Q35021678-314DD1F6-9EA4-4333-A4DF-4A3396B0EDE6Q35035263-CF361C7D-DC49-44B3-8EC9-E29D722539C4Q35587361-7F6317FE-E26A-4341-9C49-F62AD82F1E40Q35671828-532C61DB-9D0F-47F3-9A6C-682142F8C654Q35837331-6232CD69-E6B0-4031-ADE7-DC8C747B55B8Q36112982-C5E93E15-47EC-4BBF-82DF-649D82617C83Q36166755-322B0963-791F-42CC-A5AB-5AF78CC40EA9Q36422396-F1AF1BC9-0607-4C9D-B676-A0AFAF9885DBQ36514979-8C5096C9-5141-41CE-85AD-6C4113B88936Q36516977-BBEFE1B7-6277-41D2-A953-294CB21B399BQ36573517-4BB06EA8-D1B0-4D7F-AD7F-2F80EC8D2997Q36727443-AB3F42BD-D0F5-4EDD-9E18-DD231B2B68D3Q36764244-4E1FB01C-3B35-4390-B6ED-2512497D1EE0Q36941070-CE421CC0-84C5-4CD2-BFC5-880B17E0C0B7Q37146727-050AC425-5F65-4661-B572-B3EA91ACEAD6Q37225203-2661467F-8629-4C8C-90D1-77115FCE2FE7Q37349206-54C46AB1-B734-4832-B31F-416D8D209C87Q37479906-1569712D-8405-437A-9BD5-874999FC2108Q37510779-9282340B-295E-4612-9073-82A4CEB89B85Q37596337-FF18CD3C-5030-4A6E-A25F-C31C3B262B1FQ37608713-5A46CF51-2AC8-4A43-B665-2812CCA06893Q37670311-4E7549C4-EE2A-440E-BF41-0ACFB9DBE870Q38057744-2DDB1000-CCA0-47CA-B0CA-5189FECBDE49Q38092960-F82BAF9F-4B7C-4C57-88E3-54CDA8C9EE59Q38155196-B086F146-8DDB-40E9-A202-A112F0A619E7Q38198872-7CDC57B3-BC1D-413A-8881-97F5F848F56AQ38200957-3FBE476D-DC31-48B2-B4C7-9D6004DFEBA9
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Role of Nox4 in murine models of kidney disease.
@en
Role of Nox4 in murine models of kidney disease.
@nl
type
label
Role of Nox4 in murine models of kidney disease.
@en
Role of Nox4 in murine models of kidney disease.
@nl
prefLabel
Role of Nox4 in murine models of kidney disease.
@en
Role of Nox4 in murine models of kidney disease.
@nl
P2093
P50
P1476
Role of Nox4 in murine models of kidney disease
@en
P2093
Andrea Babelova
Christian Fork
Despina Avaniadi
Janet Beckmann
Judith Kosowski
Narayana Anilkumar
Oliver Jung
P304
P356
10.1016/J.FREERADBIOMED.2012.06.027
P577
2012-06-27T00:00:00Z